Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Revvity (RVTY) is anticipated to report its Q2 2025 earnings on July 28, with consensus estimates projecting $1.14 EPS (a 6.6% year-over-year decline) on revenues of $711.27 million (a 2.8% increase). Despite the expected EPS decline, Zacks' analysis, combining a positive Earnings ESP of +0.88% and a Zacks Rank #3, indicates a high probability that Revvity will surpass its consensus EPS estimate. This outlook, supported by the company's consistent record of beating estimates in the past four quarters, suggests a potential positive impact on RVTY's near-term stock performance.

Analysis

Revvity (RVTY) is approaching its Q2 2025 earnings release with a mixed but potentially bullish setup. The consensus outlook anticipates a 6.6% year-over-year decline in earnings to $1.14 per share, even as revenues are projected to grow 2.8% to $711.27 million, indicating potential margin compression. However, a key leading indicator, the Zacks Earnings ESP, is positive at +0.88%, suggesting that the most recent analyst revisions are more optimistic than the stagnant 30-day consensus. This positive ESP, combined with a Zacks Rank of #3 (Hold), creates a statistical profile that has historically resulted in an earnings beat nearly 70% of the time. This is further supported by Revvity's strong track record of surpassing consensus EPS estimates in each of the last four quarters, including a 5.21% surprise in the prior quarter. In contrast, industry peer Labcorp (LH) shows stronger expected YoY growth but has a negative ESP, making an earnings beat for them less predictable. While the quantitative signals point towards a likely positive surprise for Revvity, the ultimate market reaction will be heavily influenced by management's commentary on future business conditions and profitability.

Key Decisions for Investors

• Given the positive +0.88% Earnings ESP and a four-quarter streak of beating estimates, investors could consider positioning for a potential earnings beat ahead of the July 28 report.
• It is critical to look beyond a potential headline beat and focus on management's guidance, as the stock's sustained direction will likely be determined by commentary on the drivers behind the 6.6% year-over-year earnings decline.
• Monitor the earnings call closely for forward-looking statements on margins and revenue sustainability, as any weakness in the outlook could negate the impact of a positive earnings surprise.
• Note the contrast with peer Labcorp, whose results may provide a benchmark for industry performance; Revvity's relative strength will be a key factor even if it beats its own estimates.